Mitsubishi Tanabe Pharma - PDFSEARCH.IO - Document Search Engine

Mitsubishi Tanabe Pharma
Results: 77

#	Item
41	May 28, 2014 Press release Mitsubishi Tanabe Pharma Corporation Name Change of Consolidated Subsidiaries in Europe Add to Reading List Source URL: www.mt-pharma.co.jp Language: English - Date: 2014-05-27 21:12:50 Mitsubishi Mitsubishi Chemical Holdings Mitsubishi companies Economy of Japan Mitsubishi Pharma
42	September 25, 2013 Mitsubishi Tanabe Pharma Corporation Revision to 2Q Consolidated Financial Forecasts for Fiscal Year Ending March 31, 2014 Add to Reading List Source URL: www.mt-pharma.co.jp Language: English - Date: 2013-09-24 22:39:22 Japanese yen Mitsubishi Motors Financial forecast Economy of Japan Mitsubishi companies 2Q
43	January 29, 2013 Press Release Mitsubishi Tanabe Pharma Corporation BindRen® Granted Marketing Authorization in Europe for Treatment of Hyperphosphatemia Osaka, Japan, January 29, 2013—Mitsubishi Tanabe Pharma Corpora Add to Reading List Source URL: www.mt-pharma.co.jp Language: English - Date: 2013-01-28 06:02:14 Nephrology Electrolyte disturbances Phosphate binders Organ failure Kidney diseases Hyperparathyroidism Dialysis Secondary hyperparathyroidism Hyperphosphatemia Medicine Health Chemistry
44	February 6, 2014 Mitsubishi Tanabe Pharma Corporation Change of Representative Directors Osaka, Japan, February 6, [removed]Today, Mitsubishi Tanabe Pharma Corporation (President & Representative Director, Michihiro Tsu Add to Reading List Source URL: www.mt-pharma.co.jp Language: English - Date: 2014-02-06 01:40:56 Mitsubishi Pharma Automotive industry in Japan Mitsubishi companies Economy of Japan Mitsubishi Motors
45	September 13, 2012 Press release: Mitsubishi Tanabe Pharma Corporation MAINTATE® Tablets: Selective β1 Antagonist Notice regarding application for additional indication for chronic atrial fibrillation Osaka, Japan, Sep Add to Reading List Source URL: www.mt-pharma.co.jp Language: English - Date: 2012-09-13 02:18:00 Organic chemistry Bisoprolol Atrial fibrillation Fibrillation Cardiac dysrhythmia Chemistry Medicine
46	May 29, 2014 Press release: Mitsubishi Tanabe Pharma Corporation Announcement of Merger (Simplified Merger and Short form Merger) of Consolidated Subsidiary Add to Reading List Source URL: www.mt-pharma.co.jp Language: English - Date: 2014-05-28 22:15:41 IHI Corporation Economy of Japan Business Economy of Asia Mitsubishi companies Mitsubishi Chemical Holdings Chūō-ku Osaka
47	August 28, 2012 Press release: Mitsubishi Tanabe Pharma Corporation Daiichi Sankyo Co., Ltd. Launch of TENELIA® 20mg Tablets Add to Reading List Source URL: www.mt-pharma.co.jp Language: English - Date: 2012-08-27 03:43:16 Glucagon-like peptide-1 Mitsubishi companies Daiichi Sankyo Dipeptidyl peptidase-4 inhibitor Chūō-ku Osaka
48	April 1, 2013 PRESS RELEASE Mitsubishi Tanabe Pharma Corporation Transfer of Tanabe Europe’s shares Osaka, Japan, April 1, [removed]Mitsubishi Tanabe Pharma Corporation (President and Add to Reading List Source URL: www.mt-pharma.co.jp Language: English - Date: 2013-04-07 21:51:09 Mitsubishi Motors Mitsubishi Mitsubishi Pharma Mitsubishi companies Economy of Japan Mitsubishi Chemical Holdings
49	June 29, 2012 Press release: Mitsubishi Tanabe Pharma Corporation Daiichi Sankyo Co., Ltd. Marketing and Manufacturing Approval Received for TENELIA® 20mg Tablets Add to Reading List Source URL: www.mt-pharma.co.jp Language: English - Date: 2012-09-04 21:13:37 Mitsubishi Glucagon-like peptide-1 Economy of Asia Mitsubishi companies Mitsubishi Pharma Dipeptidyl peptidase-4 inhibitors Economy of Japan Daiichi Sankyo Chūō-ku Osaka
50	May 30, 2014 Press release Mitsubishi Tanabe Pharma Corporation Name Change of Group Company in China Add to Reading List Source URL: www.mt-pharma.co.jp Language: English - Date: 2014-05-29 21:00:35 Mitsubishi Mitsubishi Chemical Holdings Mitsubishi companies Economy of Japan Mitsubishi Pharma